1. Market Research
  2. > Pharmaceutical Market Trends

Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals

  • June 2017
  • 138 pages
  • ID: 3846784
In this report:
AS OF THE TENDER OFFER EXPIRATION, ##,##,## SHARES OF MEDIVATION COMMON STOCK WERE VALIDLY TENDERED, REPRESENTING APPROXIMATELY ##.##% OF THE SHARES OUTSTANDING.
IN ADDITION, NOTICES OF GUARANTEED DELIVERY HAVE BEEN DELIVERED FOR ##,##,## SHARES OF MEDIVATION COMMON STOCK, REPRESENTING APPROXIMATELY ##.##% OF THE SHARES OUTSTANDING.

Summary

Table of Contents

Search Inside

Partnerships, Licensing, Investments and M&A Deals and Trends for 2016 in Pharmaceuticals

Brief

GlobalData's "Alliances, Licensing, Investments and M&A Deals and Forecasts for 2016 in Pharmaceuticals" report is an vitally source of data and trend analysis on alliances, licensing, M&A and financings in the pharmaceuticals industry. The study offers exhaustive information on partnership and licensing transactions, M&As, equity/corporate debt offerings, private equity investment, and venture capital financing registered in the pharmaceuticals industry in 2016. The analysis portrays comprehensive comparative data on the number of transactions and their value in the final five years, subdivided by business deal types, different therapy areas, and geographies. On top of, The study offers data on the most important financial advisory firms in the pharmaceuticals industry.

Info exhibited in this industry report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Overview

- Analysis of the market trends for the pharmaceutical industry in the overall arena.

- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

- Analysis of partnerships, licensing, M&As, equity/corporate debt offerings, private equity investment, and venture financing deals in the pharmaceutical industry.

- Analysis of therapy areas which are very active in terms of venture capital financing, alliances, licensing agreements, equity/corporate debt offerings, and M&As.

- Analysis of deals established on distinct payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

- Analysis of partnership and licensing deals established on clinical stage of development of products.

- Summary of the pharmaceutical deals globally in the five years.

- Info on the best deals happened in the pharmaceutical industry.

- Geographies covered include - North America continent, Europe (EU), Asia Pacific (APAC), South & Central America, and the Middle East (ME) & African continent.

- League tables of financial advisors in M&As and equity/corporate debt offerings. This includes main advisors including Morgan Stanley, Credit Suisse, and Goldman Sachs

Great reasons to purchase

- Enhance your decision making capability in a more quick and time sensitive manner.

- Find out the main deal performing segments for investments in your industry.

- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

- Identify companies that are aggressively looking to raise capital in the industry

- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

- Identify the top venture capitalists, who are financing the pharmaceutical and biotech companies.

- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

- Do transactions with an understanding of how competitors are financed, and the mergers and alliances that have shaped the pharmaceutical industry.

- Identify growth segments and alternatives in each region within the industry.

- Look for main financial advisors where you are planning to raise capital from the sector or for acquisitions within the industry.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Vaccine Market: Forecast until 2022

  • $ 5650
  • Industry report
  • August 2017
  • by MarketsandMarkets

“Global vaccines market projected to grow at a CAGR of 7.5%”The vaccines market is expected to reach USD 49.27 billion by 2022 from USD 34.30 billion in 2017, at a CAGR of 7.5%. Rising prevalence of ...

Polymeric Adsorbents Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • September 2017
  • by MarketsandMarkets

“The polymeric adsorbents market is projected to grow at a CAGR of 7.9% from 2017 to 2022”The polymeric adsorbents market was valued at USD 86 million in 2016 and is projected to reach USD 135.20 million ...

Drug Discovery Services Market: Forecast until 2022

  • $ 5650
  • Industry report
  • October 2017
  • by MarketsandMarkets

“The drug discovery services market projected to grow at a CAGR of 11.6%.”The drug discovery services market was valued at USD 8.32 billion in 2017 and expected to grow at a CAGR of 11.6% to reach ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.